These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28926939)
1. Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer. Al-Awadhi FH; Salvador LA; Law BK; Paul VJ; Luesch H Mar Drugs; 2017 Sep; 15(9):. PubMed ID: 28926939 [TBL] [Abstract][Full Text] [Related]
2. Kempopeptins A and B, serine protease inhibitors with different selectivity profiles from a marine cyanobacterium, Lyngbya sp. Taori K; Paul VJ; Luesch H J Nat Prod; 2008 Sep; 71(9):1625-9. PubMed ID: 18693761 [TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Parr C; Jiang WG Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597 [TBL] [Abstract][Full Text] [Related]
4. Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis. Gunasekera SP; Miller MW; Kwan JC; Luesch H; Paul VJ J Nat Prod; 2010 Mar; 73(3):459-62. PubMed ID: 20020755 [TBL] [Abstract][Full Text] [Related]
5. Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides. Matthew S; Ross C; Rocca JR; Paul VJ; Luesch H J Nat Prod; 2007 Jan; 70(1):124-7. PubMed ID: 17253864 [TBL] [Abstract][Full Text] [Related]
6. Intramolecular modulation of serine protease inhibitor activity in a marine cyanobacterium with antifeedant properties. Matthew S; Ratnayake R; Becerro MA; Ritson-Williams R; Paul VJ; Luesch H Mar Drugs; 2010 Jun; 8(6):1803-16. PubMed ID: 20631871 [TBL] [Abstract][Full Text] [Related]
7. Largamides A-H, unusual cyclic peptides from the marine cyanobacterium Oscillatoria sp. Plaza A; Bewley CA J Org Chem; 2006 Sep; 71(18):6898-907. PubMed ID: 16930043 [TBL] [Abstract][Full Text] [Related]
8. Jizanpeptins, Cyanobacterial Protease Inhibitors from a Symploca sp. Cyanobacterium Collected in the Red Sea. Gallegos DA; Saurí J; Cohen RD; Wan X; Videau P; Vallota-Eastman AO; Shaala LA; Youssef DTA; Williamson RT; Martin GE; Philmus B; Sikora AE; Ishmael JE; McPhail KL J Nat Prod; 2018 Jun; 81(6):1417-1425. PubMed ID: 29808677 [TBL] [Abstract][Full Text] [Related]
9. Hantupeptins B and C, cytotoxic cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. Tripathi A; Puddick J; Prinsep MR; Lee PP; Tan LT Phytochemistry; 2010 Feb; 71(2-3):307-11. PubMed ID: 19913263 [TBL] [Abstract][Full Text] [Related]
10. Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer. Al-Awadhi FH; Law BK; Paul VJ; Luesch H J Nat Prod; 2017 Nov; 80(11):2969-2986. PubMed ID: 29087712 [TBL] [Abstract][Full Text] [Related]
11. Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II. Gray K; Elghadban S; Thongyoo P; Owen KA; Szabo R; Bugge TH; Tate EW; Leatherbarrow RJ; Ellis V Thromb Haemost; 2014 Aug; 112(2):402-11. PubMed ID: 24696092 [TBL] [Abstract][Full Text] [Related]
12. Structures and Activities of Tiahuramides A-C, Cyclic Depsipeptides from a Tahitian Collection of the Marine Cyanobacterium Lyngbya majuscula. Levert A; Alvariño R; Bornancin L; Abou Mansour E; Burja AM; Genevière AM; Bonnard I; Alonso E; Botana L; Banaigs B J Nat Prod; 2018 Jun; 81(6):1301-1310. PubMed ID: 29792428 [TBL] [Abstract][Full Text] [Related]
13. α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer. Han Z; Harris PK; Karmakar P; Kim T; Owusu BY; Wildman SA; Klampfer L; Janetka JW ChemMedChem; 2016 Mar; 11(6):585-99. PubMed ID: 26889658 [TBL] [Abstract][Full Text] [Related]
14. Portobelamides A and B and Caciqueamide, Cytotoxic Peptidic Natural Products from a Demirkiran O; Almaliti J; Leão T; Navarro G; Byrum T; Valeriote FA; Gerwick L; Gerwick WH J Nat Prod; 2021 Aug; 84(8):2081-2093. PubMed ID: 34269583 [TBL] [Abstract][Full Text] [Related]
15. Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer. Al-Awadhi FH; Paul VJ; Luesch H Chembiochem; 2018 Apr; 19(8):815-825. PubMed ID: 29405541 [TBL] [Abstract][Full Text] [Related]
16. Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium. Al-Awadhi FH; Gao B; Rezaei MA; Kwan JC; Li C; Ye T; Paul VJ; Luesch H J Med Chem; 2018 Jul; 61(14):6364-6378. PubMed ID: 30015488 [TBL] [Abstract][Full Text] [Related]
17. Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp. Linington RG; Edwards DJ; Shuman CF; McPhail KL; Matainaho T; Gerwick WH J Nat Prod; 2008 Jan; 71(1):22-7. PubMed ID: 18163584 [TBL] [Abstract][Full Text] [Related]
18. Tripeptides with non-code amino acids as potential serine proteases inhibitors. Markowska A; Bruzgo M; Surażyński A; Midura-Nowaczek K J Enzyme Inhib Med Chem; 2013 Jun; 28(3):639-43. PubMed ID: 22299583 [TBL] [Abstract][Full Text] [Related]
19. Biochemical studies of the lagunamides, potent cytotoxic cyclic depsipeptides from the marine cyanobacterium Lyngbya majuscula. Tripathi A; Fang W; Leong DT; Tan LT Mar Drugs; 2012 May; 10(5):1126-1137. PubMed ID: 22822361 [TBL] [Abstract][Full Text] [Related]
20. Tasipeptins A and B: new cytotoxic depsipeptides from the marine cyanobacterium Symploca sp. Williams PG; Yoshida WY; Moore RE; Paul VJ J Nat Prod; 2003 May; 66(5):620-4. PubMed ID: 12762794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]